許正宇:深化京港金融業發展合作備忘錄展現合作決心
財經事務及庫務局局長許正宇今日(11月29日)在研討會致辭稱,兩地政府簽署《深化京港金融業發展合作備忘錄》,展現了對於加強北京和香港金融合作的決心和誠意。財經事務及庫務局將會聯同各金融監管部門,秉承合作、務實、共贏原則,與北京市共同推動、落實備忘錄中的各項合作措施。
截至今年10月底,已有94家公司循新上市制度上市,首次上市集資(IPO)總額超過5,900億港元。其中,未有收入或盈利的生物科技公司有62家,集資額約1,200億港元,令香港成爲領先的生物科技公司集資中心之一。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.